The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Magnesium Sulfate 50 % w/v Solution for Injection/Concentrate for solution for infusion



EthypharmPA0549/020/001

Main Information

Trade NameMagnesium Sulfate 50 % w/v Solution for Injection/Concentrate for solution for infusion
Active SubstancesMagnesium sulphate heptahydrate
Dosage FormSolution for injection/infusion
Licence HolderEthypharm
Licence NumberPA0549/020/001

Group Information

ATC CodeB05XA Electrolyte solutions
B05XA05 magnesium sulfate

Status

License statusAuthorised
Licence Issued26/05/2006
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back